Mayweg Alexander Insider Trades

Insider Trading History

Track insider trading activity for Mayweg Alexander. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Monte Rosa Therapeutics
Monte Rosa Therapeutics GLUE
Director
Holding Value $361k 20,500 shares
Last Trade
Jun 14, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$135k 20,500 shares
$6.59
$17.59
Black Diamond Therapeutics
Black Diamond Therapeutics BDTX
Director
Holding Value $34.7k 16,500 shares
Last Trade
May 16, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$30k 16,500 shares
$1.82
$2.10
Monte Rosa Therapeutics
Monte Rosa Therapeutics GLUE
Director
Holding Value $264k 15,000 shares
Last Trade
Jun 15, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$115k 15,000 shares
$7.66
$17.59
Black Diamond Therapeutics
Black Diamond Therapeutics BDTX
Director
Holding Value $31.5k 15,000 shares
Last Trade
Jun 10, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$32.1k 15,000 shares
$2.14
$2.10
Monte Rosa Therapeutics
Monte Rosa Therapeutics GLUE
Director
Holding Value $829k 47,132 shares
Last Trade
Jun 23, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
No data
No data
$17.59
Black Diamond Therapeutics
Black Diamond Therapeutics BDTX
Director
Holding Value $31.5k 15,000 shares
Last Trade
Jun 18, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$188k 15,000 shares
$12.55
$2.10

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up